Logo Image
News
Media
Between the LinesExpert InterviewsK-CastMedical World NewsPodcastsPopulation Health PerspectivesShorts
Conferences
Partners
More
Publications
All PublicationsMHE PublicationFormulary Watch SupplementsFormulary Watch SpotlightsSupplements And Featured Publications
Events
Webinars
CME/CE
Resources
PBMI InnovatorsEmerging LeadersInteractive ToolsSponsored Content
PBM Directory

Subscribe

  • News
  • Media
  • Conferences
  • Partners
  • Publications
  • Events
  • CME/CE
  • Resources
  • PBM Directory
  • Subscribe
  • Acute Pain
  • Asthma
  • Atrial Fibrillation
  • Autoimmune Diseases
  • Biologics
  • Biosimilars
  • Blood Cancer
  • Breast Cancer
  • COVID-19
  • Cardiovascular Diseases
  • Depression
  • Dermatology
  • Diabetes
  • Digital Health
  • Drug Coverage
  • Duchenne Muscular Dystrophy
  • Eyecare
  • FDA
  • Friedreich Ataxia
  • Gene Therapy
  • Graft Versus Host Disease
  • HIV
  • Health Systems
  • Heart Failure
  • Hemophilia
  • Hypertrophic Cardiomyopathy (HCM)
  • Infectious Disease
  • Leukemia and Lymphoma
  • Liver Disease
  • Lung Cancer
  • Mental Health
  • Metabolic Dysfunction-Associated Steatohepatitis
  • Multiple Sclerosis
  • NSCLC
  • Neonatal Care
  • Nephrology
  • Obstetrics-Gynecology & Women's Health
  • Oncology
  • Oncology Biomarkers
  • Opioids
  • PTSD
  • Pediatrics
  • Plaque Psoriasis
  • Population Health
  • Post-Acute Care
  • Prescription Digital Therapeutics
  • Pulmonary Arterial Hypertension
  • RSV
  • Reproductive Health
  • Respiratory Conditions
  • Safety & Recalls
  • Schizophrenia
  • Shingles
  • Skin Cancer
  • Sleep Disorders
  • Solid Tumors
  • Spinal Muscular Atrophy
  • Substance Use Disorder
  • The Improving Patient Access Podcast
  • Type I Diabetes
  • Type II Inflammation
  • Ulcerative Colitis
  • Uro-Oncology
  • Urothelial Carcinoma
  • Vaccines
  • Women's Health
  • Year in Review- Dermatology
Spotlight -
Free Webinar: The Economics of Cell and Gene Therapy |
Our March 2026 print pub|
2026 State of Pharmacy survey results available now|
AMCP Annual 2026
Advertisement

Paul Stander

Advertisement

Articles by Paul Stander

Data helps clinicians choose options in the patient's best interest

ByPaul Stander,F. Randy Vogenberg,Paul Mullings
November 1st 2003

Hosptial program aligns high-cost clinical areas and financial strategies to realize benefits of the latest innovations

Advertisement

Latest Updated Articles

  • Data helps clinicians choose options in the patient's best interest
    Data helps clinicians choose options in the patient's best interest

    November 1st 2003



Advertisement
Advertisement

Trending on Managed Healthcare Executive

1

340B reform and drug shortages are among hospital pharmacy concerns, survey finds

2

Dual-target ADC shows promising PFS signal in mCRPC | ASCO 2025

3

Daraxonrasib trial exceeds expectations after decades of disappointment in pancreatic cancer drug development

4

Healthcare’s workforce has a scale problem, but new model is emerging

5

Chemotherapy-free drug combination shows promise for patients with KRAS-positive lung cancer | ASCO 2026

  • About Us
  • Advertise
  • Editorial
  • Contact Us
  • Terms and Conditions
  • Privacy
  • Do Not Sell My Personal Information
Contact Info

259 Prospect Plains Rd, Bldg H
Cranbury, NJ 08512

  • Formulary Watch
  • Pharmacy Benefit Management Institute
Managed Healthcare Executive
Brand Logo

© 2026 MJH Life Sciences®

All rights reserved.

Home
About Us
News
Contact Us